Loading clinical trials...
Loading clinical trials...
Evaluating Urinary CXCL10 for Enhanced Detection of Acute Rejection in Kidney Transplant Patients With Low DD-CFDNA: Diagnostic Performance and Transport Stability Across Shipping Conditions (CLEAR-CXCL10)
Conditions
Interventions
Retrospective Cohort Enrollment
Prospective Cohort Enrollment
Locations
1
United States
Virginia Commonwealth University
Richmond, Virginia, United States
Start Date
April 1, 2026
Primary Completion Date
January 1, 2027
Completion Date
January 1, 2027
Last Updated
February 17, 2026
NCT07412470
NCT07006532
NCT07275541
NCT07060716
NCT04736381
NCT04702022
Lead Sponsor
Virginia Commonwealth University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions